H 713 – Vermont

Status: Inactive / Dead
Year Introduced: 2018
Link: https://legislature.vermont.gov/bill/status/2018/H.713

Prohibits prescription drug manufacturers and wholesale distributors from engaging in price gouging in the sale of essential off-patent or generic drugs. The Department of Vermont Health Access may notify the Attorney General of any increase in the price of an essential off-patent or generic drug when: (1) the price increase, by itself or in combination with other price increases, would either: (A) result in an increase of 50 percent or more in the wholesale acquisition cost of the drug within the preceding one-year period; or (B) result in an increase of 50 percent or more in the price paid for the drug by the Department of Vermont Health Access on behalf of Medicaid beneficiaries within the preceding one-year period. Upon request, the manufacturer of a drug identified in a notice must submit additional information to the Attorney General.  The Attorney General may petition the Civil Division of the Superior Court, Washington County to, among other remedies, restore to any consumer, including a health insurer or the Department of Vermont Health Access, any money acquired as a result of a price increase that violates this bill.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found